新设备降低了血液培养的污染率
|
By LabMedica International staff writers Posted on 19 Mar 2018 |
|
图片：SteriPath Gen2血液培养物收集系统（图片蒙Magnolia医疗技术公司惠赐）。
采用机械式初始样本转移设备并培训人员后，血液培养的污染情况减少了近四分之三，且保持了20多个月。
血液培养物能帮助医生确定患者是否有严重且可能致命的血液感染，如脓毒症。抽出来的这些血也许会被病人的皮屑污染，因为皮屑里含细菌，采血的过程中皮屑会进入采血针。
研究显示，传统技术可能产生假阳性，进而使患者经受更多次抽血，住院时间延长，更易感染医院获得性病症，还可能接受不必要的抗生素治疗。美国南卡罗莱纳州查尔斯顿市南卡罗莱纳医科大学(MUSC)的科学家使用了名为SteriPath的机械式初始样本转移设备(ISDD)，它由华盛顿州西雅图市的Magnolia医疗技术公司出品，是一套封闭式无菌血液培养物收集系统，用于转移、隔离和分离最开始的1.5-2毫升血液，众所周知抽血时的这部分血液含有杂质。
研究还显示，使用机械式ISDD可能降低成本，还可提高用工效率。研究人员表示，据保守估计培养物被污染一次的耗费是4,850美元，如果研究过程中每次抽血都用ISDD，MUSC将省下74万4955美元。病理学与化验学教授Lisa Steed博士说：“开展这项研究并看到如此强烈的结果是莫大的好事，当临床医师合力解决这些问题时患者将受益无穷。血液培养物及其准确性对于确保在正确的时机按正确的过程接受正确的护理至关重要。”
该研究的论文在2017年12月11日于美国佛罗里达州奥兰多市举行的医疗促进学会全国论坛上做了宣读。MUSC医疗质量总监Danielle Scheurer大夫说：“我们看到，使用这台设备再辅以培训后，急诊科的血液培养物污染事件大幅减少。我们通过降低污染几率，提高了诊断准确率，只治疗真正感染的患者。这进而减少了抗生素的使用，让我们能够缓解当前的全国性问题——过度或不当使用抗生素导致抗生素耐药。”
Related Links:
南卡罗莱纳医科大学
Magnolia医疗技术公司
血液培养物能帮助医生确定患者是否有严重且可能致命的血液感染，如脓毒症。抽出来的这些血也许会被病人的皮屑污染，因为皮屑里含细菌，采血的过程中皮屑会进入采血针。
研究显示，传统技术可能产生假阳性，进而使患者经受更多次抽血，住院时间延长，更易感染医院获得性病症，还可能接受不必要的抗生素治疗。美国南卡罗莱纳州查尔斯顿市南卡罗莱纳医科大学(MUSC)的科学家使用了名为SteriPath的机械式初始样本转移设备(ISDD)，它由华盛顿州西雅图市的Magnolia医疗技术公司出品，是一套封闭式无菌血液培养物收集系统，用于转移、隔离和分离最开始的1.5-2毫升血液，众所周知抽血时的这部分血液含有杂质。
研究还显示，使用机械式ISDD可能降低成本，还可提高用工效率。研究人员表示，据保守估计培养物被污染一次的耗费是4,850美元，如果研究过程中每次抽血都用ISDD，MUSC将省下74万4955美元。病理学与化验学教授Lisa Steed博士说：“开展这项研究并看到如此强烈的结果是莫大的好事，当临床医师合力解决这些问题时患者将受益无穷。血液培养物及其准确性对于确保在正确的时机按正确的过程接受正确的护理至关重要。”
该研究的论文在2017年12月11日于美国佛罗里达州奥兰多市举行的医疗促进学会全国论坛上做了宣读。MUSC医疗质量总监Danielle Scheurer大夫说：“我们看到，使用这台设备再辅以培训后，急诊科的血液培养物污染事件大幅减少。我们通过降低污染几率，提高了诊断准确率，只治疗真正感染的患者。这进而减少了抗生素的使用，让我们能够缓解当前的全国性问题——过度或不当使用抗生素导致抗生素耐药。”
Related Links:
南卡罗莱纳医科大学
Magnolia医疗技术公司
Gold Member
Collection and Transport System
PurSafe Plus®
Automated MALDI-TOF MS System
EXS 3000
Gold Member
Hematology Analyzer
Medonic M32B
Latest 实验室技术 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more